Navigation Links
Dr. Ritchie Shoemaker Proudly Announces First Graduate of Shoemaker Protocol Certification Training
Date:4/4/2013

Pokomoke, MD (PRWEB) April 04, 2013

Leading biotoxin and mold illness expert Dr. Ritchie Shoemaker has recently developed a training and certification program that enables doctors to provide patients with the latest and most effective treatment for patients suffering from Chronic Inflammatory Response Syndrome (CIRS). Now, Dr. Scott McMahon, of Roswell, New Mexico, has become the first Shoemaker Protocol Certified Physician.

“We are extremely proud to be able to announce such a major accomplishment by Dr. McMahon,” wrote Dr. Shoemaker in a recent newsletter. “There is currently no board certification covering this disease [CIRS]. The closest to such an achievement is passing this CIRS Certification Program, and Dr. McMahon is the first physician in the world to have completed this rigorous testing.”

Scott W. McMahon, MD, completed his Bachelors of Science degree in Chemistry from Creighton University in 1985, and went on to complete his Medical Degree at Creighton University School of Medicine in 1989. After completing a prestigious pediatric residency at Duke University Medical Center, he has maintained board certification and practiced pediatrics in Roswell, New Mexico for 20 years. His interest in Chronic Inflammatory Response Syndrome began in 2009.

Dr. McMahon has spoken on CIRS and other topics at a number of medical meetings. He has written two books and co-authored two position statements. One statement, co-authored by Dr. Shoemaker and other experts, is the most comprehensive paper to date on CIRS and the health effects of exposure to the interior of water-damaged buildings. Dr. McMahon has participated in two “mold” trials. He maintains an office for CIRS patients in Roswell and another in Albuquerque, New Mexico.

Dr. Shoemaker continued “We anticipate many more doctors coming on line in the near term and will announce them as they complete their certification. Surviving Mold is diligently working to get certified physicians throughout the country. We are so pleased to have a doctor in the southwestern United States, so we can affirmatively answer the tens of thousands that visit our site each month, ‘Yes, we do have a doctor in your area that practices the Shoemaker Protocol!’”.

Ritchie Shoemaker, MD, is an internationally recognized leader in education, patient care, and research in the field of biotoxin related illness, and has treated over 6,000 patients. Dr. Shoemaker has written numerous papers and eight books, including the widely read Surviving Mold, and Mold Warriors. He has appeared on Good Morning America, the BBC, the Australian Broadcasting System, the Discovery Health Channel, and has spoken to the House of Representatives and the US Senate. He continues to give lectures, attend conferences on biotoxin illness, and provide one on one training to physicians working toward the Shoemaker CIRS Protocol Certification.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10588737.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Health Heroes and DMG Productions Proudly Announce Airing of New Episodes
2. The Scientist Proudly Announces the Top 10 Innovations of 2012
3. Aveka Nutra Processing proudly begins producing products from Z Trim Holdings, Inc.
4. irisnote Announces Successful Conclusion of Beta Test Phase
5. American Federation for Aging Research Announces Recipients of Irving S. Wright and Vincent Cristofalo Scientific Awards
6. PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
7. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
8. Burns Engineering Announces Expanded Selection of Miniature Temperature Sensors
9. LabRoots Announces New Cell Biology Image Contest
10. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
11. MGC Diagnostics Corporation Announces Special Cash Dividend and Extension of Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... San Antonio Texas (PRWEB) , ... ... ... announced today that it will share findings demonstrating the value of DNA ... cancer patients at this year’s San Antonio Breast Cancer Symposium. Using molecular ...
(Date:12/2/2016)... ... December 01, 2016 , ... Orthogonal, a Chicago-based medical ... FDA Class II 510(k) clearance for their flagship medical device, SimplECG. , With ... monitoring devices that rely on cloth-based nanosensors. While other companies have attempted to ...
(Date:12/2/2016)... world leader in rapid infectious disease tests, introduced the Company,s newest product, the INSTI ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , bioLytical was invited by the Clinton ... HIV Self Test to 350 pharmacy representatives in Nairobi and ...
(Date:11/30/2016)... Nov. 30, 2016 Biotest Pharmaceuticals Corporation (BPC), ... to announce the addition of its newest plasma collection ... Nebraska . The 15,200 square foot state-of-the-art facility ... 2016 and brings the total number of BPC,s plasma ... Carlisle , BPC,s Chief Executive Officer said "We are ...
Breaking Biology Technology:
(Date:11/29/2016)... France , November 29, 2016 Nearly one ... Continue Reading ... ... is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil and criminal ... monitoring, announced today that it has offered a challenge ... technology judge determine who has the largest and best ... platform, and the best customer service. "ICSolutions ... we do – which clearly is not the case ...
Breaking Biology News(10 mins):